ICCG, Inc.

Hyper-Converged Infrastructure,Application Infrastructure,Storage Management

Wallarm | November 14, 2022

Wallarm, the end-to-end API security company, today released its Q3 API ThreatStats™ Report, which provides deep analysis into all published API vulnerabilities and exploits for the quarter. The Wallarm research team dissected the data from a variety of perspectives, including software type, vendor, CVSS scores, CWEs and both OWASP Top-10 (2021) for web apps and OWASP API Security Top-10 (2019). The team also examined publicly disclosed exploit POCs to determine where the risk lies. ...

prnewswire | October 15, 2020

Frost & Sullivan's recent analysis, Strategic Analysis of the Global Vehicle-to-Everything (V2X) Market, Forecast to 2025, finds that V2X sales across the globe are projected to rise. In North America, sales are estimated to reach US$1.12 billion by 2025, while Europe and China are forecasted to reach US$3.29 billion and US$6.27 billion, respectively. Most regions prefer cellular vehicle-to-everything (C-V2X) over dedicated short-range communication (DSRC) because the technology will see...

Windows Systems and Network

Edgecore Networks | November 24, 2021

Exaware, a leading provider of Open Networking software solutions, and Edgecore Networks, the leader in Open Networking hardware solutions, today announced a global partnership agreement, to jointly provide routing solutions for Communication Service Providers (CSPs). As part of the agreement, Exaware and Edgecore will combine their experience and expertise to integrate and distribute high-end routing solutions for Internet peering, datacenter gateway, provider edge, and access/aggregation appli...

Hyper-Converged Infrastructure, Application Infrastructure

Elucidata | September 27, 2022

Elucidata, a TechBio company that powers life science research & development (R&D) with its data-centric Machine Learning Operations (ML-Ops) platform, Polly, announced that it has raised $16 million in a Series A fundraising today. The round was led by leading global investment firm Eight Roads Ventures, with participation from F-Prime Capital, IvyCap Ventures, and Hyperplane Venture Capital. The newly infused capital will be used to deepen product capabilities in translational drug res...